2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow rHIgM22: new trials by email Literature Review of rHIgM22 trials Research Report on rHIgM22
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse rHIgM22, Placebo - Multiple Sclerosis, Acute Relapsing | Phase 1 | Completed | Acorda Therapeutics | 27 | 2015-04-01 | 2018-08-22 |
| An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis rHIgM22 - Multiple Sclerosis | Phase 1 | Completed | Acorda Therapeutics | 72 | 2013-03-01 | 2015-02-27 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
United States (2)